Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Netherlands-based Bmeye has received 510(K) clearance from the FDA to market Nexfin, its newly developed line of hemodynamic monitors.
Subscribe to our email newsletter
The Nexfin monitors are said to provide provide precise and easy to use continuous non-invasive blood pressure and cardiac output monitoring. Bmeye received CE market approval earlier this year.
Bill Bednarski, CEO of Bmeye, said: “The Nexfin is cost effective and will significantly improve patient care.”